SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-198316
Filing Date
2012-05-01
Accepted
2012-05-01 07:25:16
Documents
3
Period of Report
2012-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d343595d8k.htm 8-K 13087
2 PRESS RELEASE d343595dex991.htm EX-99.1 53471
3 GRAPHIC g343595bas.jpg GRAPHIC 18605
  Complete submission text file 0001193125-12-198316.txt   93563
Mailing Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807
Business Address 1140 ROUTE 22 EAST, SUITE 304 BRIDGEWATER NJ 08807 (908) 704-1300
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 12797869
SIC: 2834 Pharmaceutical Preparations